Premium
Terminal complement inhibition dampens the inflammation during COVID‐19
Author(s) -
Kulasekararaj Austin G.,
Lazana Ioanna,
Large Joanna,
Posadas Kristina,
Eagleton Helen,
Lord Villajin John,
Zuckerman Mark,
Gandhi Shreyans,
Marsh Judith C. W.
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16916
Subject(s) - eculizumab , haemolysis , cd59 , immunology , medicine , complement system , complement component 5 , paroxysmal nocturnal hemoglobinuria , atypical hemolytic uremic syndrome , complement membrane attack complex , antibody